| Colon Neoplasm altered in cohorts of …ALTERED_INderived200 of 369show all (up to 200) |
|---|
| ← altered in cohorts of | PTPRT 348 / 461 cases (75 %) · ssm · TCGA-COAD · largest of 3 cohorts | — | — | Colon Adenocarcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF831 348 / 461 cases (75 %) · ssm · TCGA-COAD · largest of 3 cohorts | — | — | Colon Adenocarcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | DIDO1 345 / 461 cases (75 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNB1 343 / 461 cases (74 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | APC 341 / 461 cases (74 %) · ssm · TCGA-COAD · largest of 6 cohorts | — | — | Colon Adenocarcinoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | LAMA5 340 / 461 cases (74 %) · ssm · TCGA-COAD · largest of 3 cohorts | — | — | Colon Adenocarcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | CHD6 339 / 461 cases (74 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC12A5 338 / 461 cases (73 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TSHZ2 338 / 461 cases (73 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZMYND8 338 / 461 cases (73 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CDH4 337 / 461 cases (73 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RALGAPB 337 / 461 cases (73 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARFGEF2 336 / 461 cases (73 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCOA6 336 / 461 cases (73 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNFX1 335 / 461 cases (73 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ASXL1 334 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CEP250 334 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DDX27 334 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNQ2 334 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SYCP2 334 / 461 cases (72 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF335 334 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KIAA1755 333 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GNAS 332 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HELZ2 332 / 461 cases (72 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | PREX1 332 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SALL4 332 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP9A 331 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYH7B 331 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLCG1 331 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TGM2 331 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | L3MBTL1 330 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCOA5 330 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CDH26 329 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNG1 329 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MMP9 329 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NFATC2 329 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RBPJL 329 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC13A3 329 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF334 329 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCOA3 328 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NOL4L 328 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCIF1 328 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEMG2 328 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SOGA1 328 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SULF2 328 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF217 328 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZSWIM3 328 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACSS2 327 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CDH22 327 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COL20A1 327 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EPB41L1 327 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RBL1 327 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | STK4 327 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TTI1 327 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBTB46 327 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | APCDD1L 326 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CSE1L 326 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CTCFL 326 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ELMO2 326 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM83C 326 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LPIN3 326 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MATN4 326 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PHACTR3 326 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SNX21 326 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZHX3 326 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADNP 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BPIFB6 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHRNA4 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CTSA 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DLGAP4 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM217B 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GDF5 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNS1 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYBL2 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NPEPL1 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PTPN1 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RTEL1 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEMG1 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | STAU1 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TOP1 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZSWIM1 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C20orf85 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CASS4 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYP24A1 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DNMT3B 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EDEM2 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EYA2 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | JPH2 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYT1 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PABPC1L 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PPP1R16B 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SAMHD1 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SRSF6 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TAF4 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TOX2 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBP1 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZFP64 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF512B 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GDAP1L1 323 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLTP 323 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TP53 237 / 429 cases (55 %) · ssm · coad_tcga_gdc · largest of 5 cohorts | — | — | Colon Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TTN 202 / 429 cases (47 %) · ssm · coad_tcga_gdc · largest of 4 cohorts | — | — | Colon Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KRAS 183 / 429 cases (43 %) · ssm · coad_tcga_gdc · largest of 4 cohorts | — | — | Colon Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PIK3CA 127 / 429 cases (30 %) · ssm · coad_tcga_gdc · largest of 4 cohorts | — | — | Colon Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE1 122 / 429 cases (28 %) · ssm · coad_tcga_gdc · largest of 4 cohorts | — | — | Colon Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC16 121 / 429 cases (28 %) · ssm · coad_tcga_gdc · largest of 4 cohorts | — | — | Colon Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT4 99 / 429 cases (23 %) · ssm · coad_tcga_gdc · largest of 4 cohorts | — | — | Colon Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR2 86 / 429 cases (20 %) · ssm · coad_tcga_gdc · largest of 3 cohorts | — | — | Colon Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZFHX4 86 / 429 cases (20 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FSIP2 56 / 281 cases (20 %) · ssm · coad_silu_2022 · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | OBSCN 84 / 429 cases (20 %) · ssm · coad_tcga_gdc · largest of 4 cohorts | — | — | Colon Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC4 20 / 106 cases (19 %) · ssm · coad_cptac_2019 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD3 80 / 429 cases (19 %) · ssm · coad_tcga_gdc · largest of 4 cohorts | — | — | Colon Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH5 80 / 429 cases (19 %) · ssm · coad_tcga_gdc · largest of 4 cohorts | — | — | Colon Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF469 52 / 281 cases (19 %) · ssm · coad_silu_2022 · largest of 3 cohorts | — | — | Colon Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP1B 75 / 429 cases (17 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCLO 73 / 429 cases (17 %) · ssm · coad_tcga_gdc · largest of 3 cohorts | — | — | Colon Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UBR5 47 / 281 cases (17 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR3 71 / 429 cases (17 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TENM4 46 / 281 cases (16 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FBXW7 70 / 429 cases (16 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH11 69 / 429 cases (16 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | USH2A 69 / 429 cases (16 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD1 67 / 429 cases (16 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR1 67 / 429 cases (16 %) · ssm · coad_tcga_gdc · largest of 4 cohorts | — | — | Colon Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ABCA13 66 / 429 cases (15 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KIF26B 43 / 281 cases (15 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NBEAL1 43 / 281 cases (15 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRV1 65 / 429 cases (15 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT3 63 / 429 cases (15 %) · ssm · coad_tcga_gdc · largest of 4 cohorts | — | — | Colon Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | APC2 41 / 281 cases (15 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LMAN1 41 / 281 cases (15 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NEB 62 / 429 cases (14 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MSH3 40 / 281 cases (14 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SEC31A 40 / 281 cases (14 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SHANK1 40 / 281 cases (14 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BRAF 61 / 429 cases (14 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DST 61 / 429 cases (14 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP2 61 / 429 cases (14 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SOX9 61 / 429 cases (14 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MDN1 60 / 429 cases (14 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RNF43 60 / 429 cases (14 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYO16 39 / 281 cases (14 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | STAB1 39 / 281 cases (14 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYCP1 39 / 281 cases (14 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DOCK3 59 / 429 cases (14 %) · ssm · coad_tcga_gdc · largest of 3 cohorts | — | — | Colon Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HMCN2 38 / 281 cases (14 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AMER1 58 / 429 cases (14 %) · ssm · coad_tcga_gdc | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CACNA1E 58 / 429 cases (14 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2D 58 / 429 cases (14 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BLTP1 57 / 429 cases (13 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD2 57 / 429 cases (13 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDH15 57 / 429 cases (13 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SDK1 57 / 429 cases (13 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BOD1L1 37 / 281 cases (13 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DCHS2 37 / 281 cases (13 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DYNC1H1 37 / 281 cases (13 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRTM3 37 / 281 cases (13 %) · ssm · coad_silu_2022 · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UNC80 37 / 281 cases (13 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARID1A 56 / 429 cases (13 %) · ssm · coad_tcga_gdc · largest of 3 cohorts | — | — | Colon Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DMD 56 / 429 cases (13 %) · ssm · coad_tcga_gdc · largest of 3 cohorts | — | — | Colon Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ATM 55 / 429 cases (13 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE2 55 / 429 cases (13 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNHD1 36 / 281 cases (13 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RBM27 36 / 281 cases (13 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TBC1D23 36 / 281 cases (13 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TDRD6 36 / 281 cases (13 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANK3 54 / 429 cases (13 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HMCN1 54 / 429 cases (13 %) · ssm · coad_tcga_gdc · largest of 4 cohorts | — | — | Colon Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HYDIN 54 / 429 cases (13 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC5B 54 / 429 cases (13 %) · ssm · coad_tcga_gdc · largest of 3 cohorts | — | — | Colon Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ACACB 35 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CCDC73 35 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CELSR3 35 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH12 35 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HSPG2 35 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LARP7 35 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NDUFC2 35 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | POLE 35 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UBR4 35 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | WDFY4 35 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FLG 53 / 429 cases (12 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANK2 52 / 429 cases (12 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SACS 52 / 429 cases (12 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ABCC5 34 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CACNA1B 34 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CFAP46 34 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COBLL1 34 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CPLANE1 34 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH6 34 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HERC1 34 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HUWE1 34 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PIEZO2 34 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TNRC18 34 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2B 51 / 429 cases (12 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TRPS1 51 / 429 cases (12 %) · ssm · coad_tcga_gdc | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADAMTS20 33 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CLOCK 33 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH14 33 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DOCK4 33 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |